{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/023/SRR29029423/SRR29029423.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/026/SRR29029426/SRR29029426.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/022/SRR29029422/SRR29029422.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/024/SRR29029424/SRR29029424.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/025/SRR29029425/SRR29029425.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/021/SRR29029421/SRR29029421.fastq.gz"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Marikki Laiho Lab, Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA1111743"],"scientific_name":["Homo sapiens"],"long_description":["Ribosome biosynthesis is essential for cancer growth and proliferation. This dependency is therapeutically exploitable by blocking the rate-limiting step, RNA polymerase I (Pol I) transcription. Here we investigated the effects of RNA Pol I inhibitor on binding of Pol I RPA1 and Pol II Rpb1 on genomic DNA. Overall design: We treated LNCaP prostate cancer cells with either DMSO vehicle or 1 microM BMH-21 for 6 hrs."],"tag":["xref:PubMed:40553690"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"ChIP-seq analysis of RNA polymerase I inhibitor effect on Pol I and Pol II binding","description":"ChIP-seq analysis of RNA polymerase I inhibitor effect on Pol I and Pol II binding","dates":{"last_updated":"2025-09-24","first_public":"2025-05-15"},"accession":"PRJNA1111743","cross_references":{"GEO":["GSE267504"],"taxon":["9606"],"PubMed":["40553690"]}}